Send to

Choose Destination

See 1 citation found by title matching your search:

JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.

Williams DW, Anastos K, Morgello S, Berman JW.

J Leukoc Biol. 2015 Feb;97(2):401-12. doi: 10.1189/jlb.5A0714-347R. Epub 2014 Nov 24.

Supplemental Content

Loading ...
Support Center